No Detail Found!

Clinical study of Edaravone Dexborneol combined with Tirofiban in treatment of Acute Cerebral Infarction

Author(s)
Yuxia Mi Department of Neurology, Cangzhou People’s Hospital, Cangzhou 061000, Hebei, P.R. China.
Zhigang Hou Department of Neurology, Cangzhou People’s Hospital, Cangzhou 061000, Hebei, P.R. China.
Jiaqi Liu Department of Neurology, Cangzhou People’s Hospital, Cangzhou 061000, Hebei, P.R. China.
Caixia Zhang Department of Neurology, Cangzhou People’s Hospital, Cangzhou 061000, Hebei, P.R. China.
Abstract
Objective: To explore the clinical eficacy and safety of edaravone dexborneol combined with tirofiban in the treatment of acute cerebral infarction. Methods: This is a retrospective study. A total of 80 patients with acute cerebral infarction (ACI) treated in Cangzhou People's Hospital from March 2018 to December 2021 were selected, and randomly divided into the routine group(n=40) and intervention group(n=40) according to the principle of random draw. Neurological deficits in the two groups were evaluated and compared before and after treatment using the National Institutes of Health Stroke Scale (NIHSS). The quality of life of the patients was evaluated by the modified Rankin Scale (mRS). Results: Before treatment, NIHSS and mRS scores of the two groups were not statistically significant( p>0.05); the levels of Vmin and Qmin in the two groups showed no statistical significance( p>0.05); no statistical significance was found in CRP or IL-6 levels between the two groups(p>0.05). After treatment for 14 days, the NIHSS and mRS scores of the two groups both decreased, which was more significant in the intervention group(p0.05). Conclusion: Edaravone dexborneol combined with tirofiban in the treatment of ACI can efectively improve patients' neurological deficits, quality of life and cerebral blood flow, and reduce inflammatory factor levels, have significant clinical eficacy and high clinical treatment safety.
Publication Details
Page(s) 190-194
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Acute cerebral infarction, Inflammatory factor, Tirofiban, Edaravone dexborneol, Hemodynamic index
0

Citations

0

Downloads

78

Views